Journal of Stem Cell Research & Therapy

Cell therapy and its emerging markets

6^th International Conference and Exhibition on Cell and Gene Therapy

March 27-28, 2017 Madrid, Spain

Deven Patel

Global Institute of Stem Cell Therapy and Research, USA

Posters & Accepted Abstracts: J Stem Cell Res Ther

Abstract:

The field of stem cell research has come a long way from the early days of bone marrow transplant and has progressed into the sophisticated domain of embryonic and induced pluripotent stem cell. It has addressed the risks that were faced during the emergence of genetic engineering. In fact, it has reached critical mass with a number of private sector companies carrying out cuttingedge research and a number of governments recognizing the significant impacts it would have on the well-being of humanity with the promise of significant reduction of the healthcare costs. We are already seeing evidence of positive impact on patients suffering from several degenerative and neurodegenerative diseases such as diabetes, arthritis, autism, Alzheimer's and multiple sclerosis. Furthermore, it is only going to get better, once the advance research meets the motivation of governments and capital markets to bring this epoch-making technology to market and help cure many incurable diseases for the first time in human history.

Biography :

Email: Deven@giostar.com